These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15118733)

  • 21. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes.
    Ettinger U; Joober R; DE Guzman R; O'driscoll GA
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):764-7. PubMed ID: 17109713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.
    Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS
    Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal transducer and activator of transcription 6 (STAT6) and attention-deficit hyperactivity disorder: a speculative hypothesis.
    Tsai SJ
    Med Hypotheses; 2006; 67(6):1342-4. PubMed ID: 16844317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder.
    Simsek M; Al-Sharbati M; Al-Adawi S; Ganguly SS; Lawatia K
    Clin Biochem; 2005 Aug; 38(8):739-42. PubMed ID: 15993876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetics of attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T
    Expert Rev Neurother; 2009 Oct; 9(10):1547-65. PubMed ID: 19831843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review: Genetics of attention deficit/hyperactivity disorder.
    Wallis D; Russell HF; Muenke M
    J Pediatr Psychol; 2008; 33(10):1085-99. PubMed ID: 18522996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the calcyon gene (DRD1IP) with attention deficit/hyperactivity disorder.
    Laurin N; Misener VL; Crosbie J; Ickowicz A; Pathare T; Roberts W; Malone M; Tannock R; Schachar R; Kennedy JL; Barr CL
    Mol Psychiatry; 2005 Dec; 10(12):1117-25. PubMed ID: 16172615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder.
    Okamura N; Hashimoto K; Iyo M; Shimizu E; Dempfle A; Friedel S; Reinscheid RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1444-8. PubMed ID: 17669576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating epigenetic influences on seizure disposition.
    Gilby KL
    Can J Neurol Sci; 2009 Aug; 36 Suppl 2():S78-81. PubMed ID: 19760910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin-dopamine interaction: an overview.
    Esposito E; Di Matteo V; Di Giovanni G
    Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.
    Capp PK; Pearl PL; Conlon C
    Expert Rev Neurother; 2005 May; 5(3):325-31. PubMed ID: 15938665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
    Morice E; Denis C; Giros B; Nosten-Bertrand M
    Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology.
    Retz W; Retz-Junginger P; Supprian T; Thome J; Rösler M
    Behav Sci Law; 2004; 22(3):415-25. PubMed ID: 15211560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging the genetics of executive function.
    Greene CM; Braet W; Johnson KA; Bellgrove MA
    Biol Psychol; 2008 Sep; 79(1):30-42. PubMed ID: 18178303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.